Near-infrared fluorescent imaging of tumor apoptosis

Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
Cancer Research (Impact Factor: 9.33). 04/2003; 63(8):1936-42.
Source: PubMed


Noninvasive imaging using radioactive annexin V is an emerging strategy for the assessment of cell death in vivo (F. G. Blankenberg, and H. W. Strauss. Apoptosis, 6: 117-123, 2001.). Therefore, we investigated whether annexin V labeled with the fluorophore Cy5.5 (Cy) could serve as a probe for imaging of tumor apoptosis using near infrared fluorescence (NIRF). We prepared active Cy-annexin (an equimolar dye:protein ratio) that bound to apoptotic Jurkat T cells and an inactive Cy-annexin probe (>2 dyes/mol protein) that did not. Active Cy annexin was used to image a 9L gliosarcoma, constitutively expressing green fluorescent protein marker, and the CR8 variant of Lewis lung carcinoma, stably transfected to express DsRed2. The expression of transfected fluorescent protein provided an indication of tumor margins and a means of defining tumor-associated NIRF signal intensity with both tumor models. Tumors were imaged with and without cyclophosphamide treatment. In both tumor models active Cy-annexin V tumor NIRF signal increased two to three times after the treatment. Tumor NIRF signal developed by 75 min after active Cy-annexin injection and remained for a 20-h observation period. Inactive annexin V was used as a control in the CR8 carcinoma experiments and resulted in a low nonspecific signal. With the 9L gliomosacrcoma model, active Cy-annexin V bound to both tumor cells (Cy-annexin V staining only) and endothelial cells (costained with Cy-annexin V and antibody to the endothelial marker CD31). Our results demonstrate that active Cy-annexin can be used as a NIRF probe to image apoptosis from outside an intact living animal and may provide nonradioactive method of measuring the antiproliferative effects of cancer chemotherapeutic regimens.

Download full-text


Available from: Eyk Schellenberger, Jul 21, 2014
  • Source
    • "ICG is an anionic, amphiphilic, tricarbocyanine probe, which allows it to have a high affinity for proteins, such as albumin, and allows visualization of solid tumors, but may also cause higher levels of nonspecific binding.[5] Similar to fluorescein, ICG provides nonspecific contrast in areas of permeable neurovasculature.[78108] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The clinical application of fluorescent contrast agents (fluorescein, indocyanine green, and aminolevulinic acid) with intraoperative microscopy has led to advances in intraoperative brain tumor imaging. Their properties, mechanism of action, history of use, and safety are analyzed in this report along with a review of current laser scanning confocal endomicroscopy systems. Additional imaging modalities with potential neurosurgical utility are also analyzed. Methods: A comprehensive literature search was performed utilizing PubMed and key words: In vivo confocal microscopy, confocal endomicroscopy, fluorescence imaging, in vivo diagnostics/neoplasm, in vivo molecular imaging, and optical imaging. Articles were reviewed that discussed clinically available fluorophores in neurosurgery, confocal endomicroscopy instrumentation, confocal microscopy systems, and intraoperative cancer diagnostics. Results: Current clinically available fluorescent contrast agents have specific properties that provide microscopic delineation of tumors when imaged with laser scanning confocal endomicroscopes. Other imaging modalities such as coherent anti-Stokes Raman scattering (CARS) microscopy, confocal reflectance microscopy, fluorescent lifetime imaging (FLIM), two-photon microscopy, and second harmonic generation may also have potential in neurosurgical applications. Conclusion: In addition to guiding tumor resection, intraoperative fluorescence and microscopy have the potential to facilitate tumor identification and complement frozen section analysis during surgery by providing real-time histological assessment. Further research, including clinical trials, is necessary to test the efficacy of fluorescent contrast agents and optical imaging instrumentation in order to establish their role in neurosurgery.
    Surgical Neurology International 04/2014; 5(1):60. DOI:10.4103/2152-7806.131638 · 1.18 Impact Factor
  • Source
    • "Apoptosis imaging is based on the close integration of annexin-V as a a phosphatidylserine exposed exposed on the cell surface and is also related to the cell's internal activation. Petrovsky et al. [85] used the near-infrared fluorescent dye, Cy5.5-labeled annexin-V, as the NIRF probe to image tumor apoptosis and may provide a nonradioactive method of measuring the antiproliferative effects of cancer chemotherapeutic regimens. Maxwell et al. [86] developed a cell-penetrating NIRF probe based on an activatable strategy to detect apoptosis-associated caspase activity for enhanced noninvasive analysis of apoptosis in whole cells and live animals. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Optical molecular imaging, a new medical imaging technique, is developed based on genomics, proteomics and modern optical imaging technique, characterized by non-invasiveness, non-radiativity, high cost-effectiveness, high resolution, high sensitivity and simple operation in comparison with conventional imaging modalities. Currently, it has become one of the most widely used molecular imaging techniques and has been applied in gene expression regulation and activity detection, biological development and cytological detection, drug research and development, pathogenesis research, pharmaceutical effect evaluation and therapeutic effect evaluation, and so forth, This paper will review the latest researches and application progresses of commonly used optical molecular imaging techniques such as bioluminescence imaging and fluorescence molecular imaging.
    02/2014; 2014(6):429198. DOI:10.1155/2014/429198
  • Source
    • "In terms of biomarkers, there are two different methods to detect a neoplasia: using epigenetic markers on tissues during cancer development or utilizing ligands produced by the developed cancer. Several kinds of molecules or epitopes can be targeted, such as those involved in genetic mutations in the APC, KRAS, and p53 genes, microsatellite instability,20,24 and apoptosis.25 Endostatin and proteases such as cathepsin B are upregulated in areas of focal invasion of colorectal carcinomas and in dysplastic adenomas.20,24,26 "
    [Show abstract] [Hide abstract]
    ABSTRACT: During the last decade, researchers have made great progress in the development of new image processing technologies for gastrointestinal endoscopy. However, diagnosis using conventional endoscopy with white light optical imaging is essentially limited, and ultimately, we still rely on the histopathological diagnosis from biopsy specimens. Molecular imaging represents the most novel imaging methods in medicine, and the future of endoscopic diagnosis is likely to be impacted by a combination of biomarkers and technology. Endoscopic molecular imaging can be defined as the visualization of molecular characteristics with endoscopy. These innovations will allow us not only to locate a tumor or dysplastic lesion but also to visualize its molecular characteristics and the activity of specific molecules and biological processes that affect tumor behavior and/or its response to therapy. In the near future, these promising technologies will play a central role in endoluminal oncology.
    Clinical Endoscopy 11/2013; 46(6):603-610. DOI:10.5946/ce.2013.46.6.603
Show more